MARKET WIRE NEWS

Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-13 13:59:17 ET

Acurx Pharmaceuticals, Inc. (ACXP)

Q1 2025 Earnings Conference Call

May 13, 2025 08:00 AM ET

Company Participants

Robert Shawah - Co-Founder and CFO

David Luci - President and CEO

Conference Call Participants

Joanne Lee - Maxim Group

James Molloy - Alliance Global Partners

Presentation

Operator

Greetings and welcome to the Acurx Pharmaceuticals First Quarter 2025 Financial Results and Business Update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded....

Read the full article on Seeking Alpha

For further details see:

Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
Acurx Pharmaceuticals Inc.

NASDAQ: ACXP

ACXP Trading

-7.81% G/L:

$5.015 Last:

4,365,725 Volume:

$5.24 Open:

mwn-alerts Ad 300

ACXP Latest News

ACXP Stock Data

$5,246,237
2,029,733
5.06%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Staten Island

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App